Riskpilot← Back to searchSign inGet full accessMP Stenman Aktiebolag
ABActiveOrg 5593460206Krokebäcksvägen 107General medical practice activities · NACE 8621Est. 20211 employees
Revenue 2025
SEK 338K
+15% vs 2024
EBITDA margin
56.6%
+98% vs 2024
Equity ratio
70.8%
Financial strength
Net profit 2025
SEK 152K
+111% vs 2024
| Revenue | SEK 338K | +15% |
| EBITDA | SEK 191K | +98% |
| Net profit | SEK 152K | +111% |
| Total assets | SEK 353K | +111% |
| Equity | SEK 249K | +155% |
| Employees | 1 | — |
Legal name
MP Stenman Aktiebolag
Org number
5593460206
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva konsultverksamhet med läkartjänster och prästtjänster, samt därmed förenlig verksamhet.
Address
Krokebäcksvägen 107
Email
stenman.maria@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 188 | 539 | 293 | 338 |
| Staff expenses | −9 | −174 | −44 | −38 |
| EBITDA | 130 | 219 | 96 | 191 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 130 | 219 | 96 | 191 |
| Net financials | — | 0 | −0 | 0 |
| Profit before tax | 130 | 220 | 96 | 191 |
| Tax | −27 | −47 | −24 | −39 |
| Net profit | 103 | 173 | 72 | 152 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 176 | 328 | 167 | 353 |
| Equity | 128 | 198 | 98 | 249 |
| Long-term debt | — | — | — | — |
| Short-term debt | 48 | 131 | 69 | 103 |
| Total debt | 48 | 131 | 69 | 103 |
EBITDA margin
56.6%
This company
15.8%
Market median
+258% vs market
20222025
Equity ratio
70.8%
This company
38.2%
Market median
+85% vs market
20222025
Return on equity
60.8%
This company
18.4%
Market median
+230% vs market
20222025
Net profit margin
45.0%
This company
8.1%
Market median
+456% vs market
20222025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20222025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-15 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MP Stenman Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Maria Stenman | Chief Executive Officer | 0 companies |
| Lars Peter Alexander Stenman | Chairman | 0 companies |
| Eric David Christoffer Stenman | Deputy Board Member | 0 companies |